why choose us

First received: January 17, 2023

Clinical Trial: Daily Online Adaptive Short-Course Radiation Therapy and Concurrent Chemotherapy for Muscle-Invasive Bladder Cancer

Study Status: Completed

Recruit Status: RECRUITING

Condition: Muscle Invasive Bladder Urothelial Carcinoma

Study Type: INTERVENTIONAL


Official Title: Daily Online Adaptive Short-Course Radiation Therapy and Concurrent Chemotherapy for Muscle-Invasive Bladder Cancer: A Prospective Trial of an Individualized Approach for Reducing Bowel and Bladder To

Brief Summary: This trial is a single-arm, prospective, multi-center clinical trial designed to demonstrate that adaptive radiotherapy for muscle-invasive bladder cancer will translate into a decreased rate of acute (assessed weekly during chemo-radiotherapy) grade 3 or greater gastrointestinal/genitourinary toxicity compared with the historically reported rate for non-adaptive radiation therapy.The Common Terminology Criteria for Adverse Events (CTCAE) version 5 assessment tool will be utilized.

Read more